Abstract
Introduction
Bacillary angiomatosis (BA), also termed epithelioid angiomatosis, is an angioproliferative disease first described in 1983 by Stoler et al. [1] . It has occurred most commonly in patients with severe immunosuppression caused by the human immunodeficiency virus (HIV). BA has only rarely been discovered in patients with other kinds of immunosuppression, such as organ transplant recipients or immunocompromised individuals [2, 3] . The disease derived its name from the vascular proliferation seen in histological tissue examination and from the presence of numerous bacillary organisms detectable in Warthin-Starry silver staining or electron microscopy [4] ( fig. 1c) . In recent years, molecular biological techniques, which allow for an exact pathogen typing, have become established [5] (fig. 1d ).
The first described clinical manifestation of an infection with organisms of the Rochalimaea genus (now known as Bartonella) was called 'trench fever' as it appeared among the battlefield troops in World War I [6] . In 1990, Relman et al. [7] recognized a relationship between the 'trench fever' microorganism and the bacterium Rochalimaea quintana (now Bartonella quintana), the agent of BA. In 1992, another member of the genus Bar- Fig. 1 . 53-year-old HIV-infected patient with BA manifestations of the skin, liver, bones and pancreas as well as pronounced general symptoms and a weight loss of 15 kg. The patient was treated with 2 g/day of erythromycin per os for 12 weeks. This therapy led to a complete remission of all lesions and an increase in weight by 18 kg. Until the time of evaluation (12 months after the end of the therapy), the patient had no relapse of BA. a A 3 ! 5 cm ulcerated nodule on the patient's shoulder which, later, was completely excised surgically. b The lytic bone lesion of a thoracic vertebra. c The tissue from a under an electron microscope. Multiple bacteria can be seen with the form and wall structure characteristic of the Bartonella group pathogen. d The polymerase chain reaction in the focus from a. tonella, B. henselae, was also recognized to be associated with this illness [8] . BA typically presents itself as an inflammatory disease, most often involving the skin. Cutaneous lesions may be solitary or multiple and can be localized superficially, in the skin or subcutaneously ( fig. 1a ). In addition, oral, anal, conjunctival and gastrointestinal mucosal surfaces, as well as the liver, bones, lymph nodes, spleen and several other organs may be involved ( fig. 1b) . These lesions grow slowly over a period of several weeks. In patients afflicted with this disorder, other symptoms like fever, loss of weight or an overall feeling of illness typically appear. On histological examination, lesions of BA consist of lobular proliferations of small blood vessels containing plump, cuboidal endothelial cells. These are interspersed with mixed inflammatory cell infiltrates having a predominance of neutrophils [9] . Because of the infrequent occurrence of BA, there is no uniform scheme of therapy, but, in patients with HIV infections, experienced clinicians recommend antibiotic treatment with oral erythromycin or doxycycline over a period of 8-12 weeks [10] .
In 1993, the first cases of BA were described in Germany [11, 12] . Although a few cases were reported during the following years [13] , no synopsis of the different BA infections in Germany was carried out.
Consequently, we conducted a retrospective investigation with various centers of the German AIDS Study Group to obtain epidemiological and clinical data on Plettenberg/Lorenzen/Burtsche/Rasokat/ Kaliebe/Albrecht/Mertenskötter/Bogner/ Stoehr/Schöfer HIV-associated BA in Germany. To our knowledge, this study describes the largest published series of HIVinfected patients with BA in a clearly characterized region of Europe.
Methods
We conducted a retrospective multicenter study in Germany in order to analyze epidemiological and clinical data of patients with HIV-associated BA. 23 German HIV centers (see appendix) associated with the German AIDS Study Group (GASG/IdkF) participated in this evaluation. Standardized data on the medical histories of all HIV-infected patients with BA were gathered in the period form January 1, 1990 , to December 31, 1998. To verify the diagnosis of BA there had to be typical clinical manifestations in combination with histological findings of respective bacteria in Warthin-Starry staining or electron microscopy or identification of the Bartonella species by molecular biological techniques. General demographic data were analyzed as well as details of clinical manifestation and diagnosis of BA, treatment and clinical outcome. This study was conducted with the support of the AIDS-Center of the Robert Koch Institute/Bundesministerium für Gesundheit file 415-4476-09/25.
Results
Between 1990 and 1998, 23 HIV centers associated with the GASG/IdkF treated a total of 17,626 HIVinfected patients. During this period, 21 cases of BA were documented. The prevalence of BA was therefore 11.9 cases/10,000 HIV-infected patients. Of these 21 patients, 19 were male and 2 female. The median age was 39 years (26-71 years). Nineteen patients (90%) had CD4-positive lymphocytes less than 100 cells/Ìl, but 2 had distinctly more than 300 cells/Ìl (350, 405 cells/Ìl). The median CD4 cell count was 30 cells/Ìl (0-405 cells/Ìl). According to the classification of the Centers for Disease Control, in 13 of the 21 individuals the stage of the HIV infection was C (AIDS), in 6 patients B3 and in 2 B2. Nine patients had been afflicted with Kaposi's sarcoma in their medical history, 6 with Pneumocystis carinii pneumonia and 4 patients with cytomegalovirus infections; in 4 cases, esophageal candidiasis had been diagnosed and 2 patients had cerebral toxoplasmosis.
In 18 cases, the diagnosis of BA was verified by Warthin-Starry staining, in 4 patients electron microscopy was performed and in 3 patients molecular biological methods were applied.
In 19 out of the 21 patients with BA the skin was involved, in 5 cases the bones were infected and 4 patients had manifestations in the liver. Three of the individuals had BA of the lymph nodes. In 2 patients, the mucous membranes were involved. One patient had a manifestation of the spleen and another of the central nervous system (table 1) .
In the cases of cutaneous BA, the median number of lesions was 9 (1-80). In 12 cases, they were localized at the lower extremities, in 11 patients at the upper extremities, 8 patients had manifestations of the trunk, another 8 on the head and 2 patients had mucocutaneous manifestations of the oral cavity.
All 19 patients with cutaneous manifestations had dermal papules or nodules; 8 cases showed additionally ulceration and crusting. In 4 patients, plaques were described. Systemic symptoms were documented in 11 patients: the symptoms involved fever in 9 patients, weight loss in 3 and nighttime sweating in 4 cases. Only 11 patients were found to have had contact with cats. In 10 cases, no contact with cats was documented. One patient owned a cat but denied being scratched. Out of 21 patiens with BA, 20 received antibiotic therapy. In 15 patients, erythromycin was used; 2 patients received doxycyline, while 3 other patients were each treated with amoxillin/clavulanic acid, cefuroxime and imipenem. Thirteen patients had a complete remission, while in 7 patients only a partial response was observed. The median duration of treatment was 28 days (5-240 days). The median time needed to achieve a complete response was 36 days (19-240 days). However, 3 patients with a complete response and 4 patients with a partial response had a relapse after antibiotic therapy. Four of the 7 patients with relapses were treated with erythromycin; each was treated with imipenem, amoxicillin and cefuroxime. The antibiotic therapy of the 7 patients lasted a median of 21 days (13-88 days). After completion of the antibiotic therapy, the median time of relapse was 5 weeks (3-16 weeks).
Up to the time of evaluation, 7 patients had died ( fig. 2) . The median duration between time of diagnosis of BA and death was 8 months (0-34 months). One of these patients died from peliosis hepatis with dissemination to multiple organs including the lungs and the bones before therapy could be initiated. Although the patient did not present any skin lesions that could have suggested BA, the infection was diagnosed on autopsy. In the other deceased patients, the shortest time between diagnosis of BA and death was 2 months. In none of these 6 cases was BA the cause of death. All patients died from other complications of their HIV infection. 
Discussion
Despite the common occurrence of Bartonella infections with more than 40,000 cases of cat scratch disease each year in the USA, BA remains a rare disorder. The prevalence of BA in the presented study was 1.2 cases/ 1,000 HIV-infected patients. LeBoit [4] estimated 1 case of BA for every 25-50 afflictions with Kaposi's sarcoma. Under the assumption that Kaposi's sarcoma makes up about 20% of the manifestations in patients with AIDS, in our study population LeBoit's estimation would forecast 125-250 AIDS patients with BA. Considering the fact that the number of HIV-infected patients is about three times higher than of those with AIDS, LeBoit's estimations correspond quite well with our results. Nevertheless, presumably even today not all cases of BA are diagnosed and the implementation of antibiotic prophylactics (e.g. with cotrimoxazole or clarithromycin) considerably affects the incidence of BA. In accordance with Cockerell, we observed that most of the affected patients (90%) had a severe immunosuppression with less than 100/Ìl CD4 cells [14] ; however, 2 of the 21 patients had significantly more than 200/Ìl CD4 lymphocytes.
A frequently recurring topic in the medical literature on BA is the question of pathogen transmission via cats. Tappero et al. [15] were able to show an association between the appearance of BA and previous scratching by cats. For various Bartonella infections, arthropods were able to be identified as vectors: B. bacilliformis is transmitted by sand flies, B. quintana by body lice and B. henselae by cat fleas [5, 16] . Correspondingly, Koehler et al. [5, 17] and Gasquet et al. [18] discovered an association betwen B. quintana infections and homelessness or low social standard as well as between B. henselae infections and contact with cats. Even today, it is still not clear whether B. henselae is transmitted to humans via direct contact with cats or via the vector of the cat flea. In our study, previous traumatic or atraumatic contact with cats could only be verified for 11 of the 21 patients. Ten patients had no previous contact with cats while the only patient who owned a cat denied having any traumatic contact with the pet.
As many authors have already pointed out, our findings verified the skin as the most frequently affected organ [19, 20] . In our study, 90% of the patients had lesions of the skin and 24% of the bones. Cockerell [14] states that infection of the bones occurs in 35% of the cases.
Although antibiotic therapies had been initiated in all premortally diagnosed cases, the rate of complete remission in the described patients was only 70%. The reasons for this poor outcome is probably the comparatively short duration of therapy, with an average of 35 days. The current medical literature recommends a treatment of 8-16 weeks [10] . This may also be the explanation for the high rate of relapses (28%).
The work presented here was largely based on the diagnosis of BA by Warthin-Starry staining in combination with clinical findings. Molecular biological techniques, like PCR, which is today commonly used for verification and identification of pathogens, were for the most part not yet available at the time of the described BA cases [5] . Nevertheless, a high level of clinical suspicion remains the most important first step to the diagnosis of BA in HIVinfected patients.
